Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval)
1 clinical trials · Condition
◉ Watch Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval)
| Record | Firm | Date |
|---|---|---|
| A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma (NCT02601950) | Epizyme, Inc. | 2015-12-22 |
Track Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval) automatically
Every clearance here is in the API, with alerts when new ones post.